Detall de la convocatòria

Característiques

Característica
Característiques principals
Outcomes research seeks to understand the end results of particular healthcare practices and interventions. End results include effects that people experience and care about, such as change in the ability to function. In particular, for individuals with chronic conditions – where cure is not always possible – end results include quality of life as well as mortality. By linking the care people get to the outcomes they experience, outcomes research has become the key to developing better ways to monitor and improve the quality of care.

The award is intended to encourage outcomes research in haemophilia and other hereditary bleeding disorders. Over the last decade a range of outcome assessment tools have been developed to record the natural history of bleeding disorders and the result of therapeutic interventions. In this category we would therefore like to invite applications that look at further development of relevant tools of outcome assessment or their validation and applications in different health care situations. Examples of the types of projects that might be considered for this award include, but are not limited to, those related to:
  • Use of different clinimetric instruments to assess bleeding disorders and the outcome of therapeutic interventions
  • Health economic outcomes research
  • Patient-reported outcomes and patient preferences
  • Quality of life.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
    Marta López: mlopez4@imim.es Ext.: 1576
    Carol Barnwell: cbarnwell@imim.es Ext.1670
    Convocatòria (URL)
    http://www.bayer-hemophilia-awards.com/awards/
    Requisits
    This specific one-off award category is open to healthcare professionals who are also eligible for the main categories, i.e. clinicians, investigators and allied healthcare professionals affiliated with a facility that carries out research into inherited bleeding disorders, or provides care to patients with such disorders.
    Dotació
    The maximum grant is US $25,000 per year.
    Durada
    One or two years
    AVÍS IMPORTANT
    Letters of Intent will be reviewed and only selected applicants will be invited to submit a full proposal.

    Arxius

    Arxiu
    Bayer Hemophilia Awards Program _ Awards.pdf
    ORA_ LOI_master_2016 (2).docx